Pisegna J, Holtmann G, Howden C W, Katelaris P H, Sharma P, Spechler S, Triadafilopoulos G, Tytgat G
Division of Gastroenterology and Hepatology, VA Greater Los Angeles Health Care System, Los Angeles, CA 90073, USA.
Aliment Pharmacol Ther. 2004 Dec;20 Suppl 9(Suppl 9):47-56. doi: 10.1111/j.1365-2036.2004.02240.x.
The major oesophageal complications associated with persistent gastro-oesophageal reflux disease (GERD) include erosive oesophagitis, ulceration, strictures and gastrointestinal (GI) bleeding. Although the causes of these complications are uncertain, studies indicate that erosive oesophagitis may progress to the development of ulcers, strictures and GI bleeding. Pharmacological treatment with proton pump inhibitors is favoured over that with H(2)-receptor antagonists for the treatment of strictures. The treatment of strictures is accomplished with dilation and many favour the concomitant use of proton pump inhibitors. Most gastroenterologists are seeing far fewer oesophageal strictures these days since the introduction of proton pump inhibitors. In addition, research has shown that oesophageal complications have a greater impact on patients suffering from night-time GERD than on those suffering from daytime GERD. Barrett's oesophagus is a significant complication associated with persistent GERD and those at risk generally experience a longer duration of symptoms, especially those with a high degree of severity. In addition, there is a strong relationship between Barrett's oesophagus and oesophageal adenocarcinoma. This is in part due to the association of obesity and the development of hiatal hernias. Furthermore, endoscopic screening is being used to detect Barrett's oesophagus and oesophageal adenocarcinoma in persons suffering from chronic GERD, even though screening may not have an impact on outcomes (Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: The AGA Chicago Workshop. Gastroenterology 2004; 127: 310-30.).
与持续性胃食管反流病(GERD)相关的主要食管并发症包括糜烂性食管炎、溃疡、狭窄和胃肠道(GI)出血。虽然这些并发症的病因尚不确定,但研究表明,糜烂性食管炎可能会发展为溃疡、狭窄和GI出血。在治疗狭窄方面,质子泵抑制剂的药物治疗比H2受体拮抗剂更受青睐。狭窄的治疗通过扩张来完成,许多人赞成同时使用质子泵抑制剂。自从引入质子泵抑制剂以来,如今大多数胃肠病学家见到的食管狭窄要少得多。此外,研究表明,食管并发症对夜间GERD患者的影响比对白天GERD患者的影响更大。巴雷特食管是与持续性GERD相关的一种重要并发症,有风险的患者通常症状持续时间更长,尤其是那些严重程度较高的患者。此外,巴雷特食管与食管腺癌之间存在密切关系。这部分归因于肥胖与食管裂孔疝的发生有关。此外,内镜筛查正被用于检测慢性GERD患者中的巴雷特食管和食管腺癌,尽管筛查可能对结果没有影响(夏尔马P、麦奎德K、登特J等。巴雷特食管诊断和管理的批判性综述:美国胃肠病学会芝加哥研讨会。《胃肠病学》2004年;127:310 - 30)。